ARCHIVES

FDA Approves Avastin For Recurrent NSCLC

This article is from The Cancer Letter archive.

Vol. 29 No. 10 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

Prostatectomy Lowers Death Risk Compared to Watchful Waiting

April 29, 2011

COG’s Peter Adamson Has A Conversation With The Cancer Letter

March 15, 2013

Managed Care Limits Access To Trials, Cancer Panel Says

August 11, 1995

New P01 Guidelines Will Go Into Effect Feb. 1 Not Oct. 1

September 16, 1983

In Brief; NCAB To Hear Report On Human Cancer Virus, Mayo Projects, Proposed FDA Regulations

February 28, 1975

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001